Mraz Amerine & Associates’s Nutrien NTR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.46M Sell
23,130
-95
-0.4% -$6.64K 0.21% 75
2026
Q1
$1.75M Sell
23,225
-183
-0.8% -$13.1K 0.26% 66
2025
Q4
$1.44M Sell
23,408
-671
-3% -$39.5K 0.21% 73
2025
Q3
$1.41M Sell
24,079
-350
-1% -$20.4K 0.22% 72
2025
Q2
$1.42M Buy
24,429
+1,501
+7% +$84.8K 0.23% 66
2025
Q1
$1.15M Sell
22,928
-562
-2% -$28.8K 0.2% 74
2024
Q4
$1.05M Buy
23,490
+541
+2% +$25.7K 0.19% 77
2024
Q3
$1.1M Buy
22,949
+2,441
+12% +$118K 0.2% 80
2024
Q2
$1.04M Buy
20,508
+1,120
+6% +$61.3K 0.21% 75
2024
Q1
$1.05M Buy
19,388
+853
+5% +$44.5K 0.2% 76
2023
Q4
$1.04M Buy
18,535
+1,369
+8% +$77.4K 0.22% 76
2023
Q3
$1.06M Buy
17,166
+522
+3% +$33K 0.24% 73
2023
Q2
$983K Buy
16,644
+793
+5% +$50.5K 0.23% 75
2023
Q1
$1.17M Buy
15,851
+1,093
+7% +$84.3K 0.29% 67
2022
Q4
$1.08M Buy
14,758
+6,926
+88% +$547K 0.25% 71
2022
Q3
$653K Buy
7,832
+1,238
+19% +$106K 0.18% 81
2022
Q2
$525K Hold
6,594
0.13% 94
2022
Q1
$686K Hold
6,594
0.16% 89
2021
Q4
$496K Hold
6,594
0.13% 101
2021
Q3
$427K Hold
6,594
0.12% 111
2021
Q2
$400K Hold
6,594
0.11% 116
2021
Q1
$355K Sell
6,594
-200
-3% -$10.9K 0.1% 112
2020
Q4
$327K Sell
6,794
-1,200
-15% -$53K 0.11% 108
2020
Q3
$314K Buy
7,994
+1,260
+19% +$45.9K 0.12% 96
2020
Q2
$216K Buy
6,734
+200
+3% +$6.96K 0.08% 120
2020
Q1
$222K Sell
6,534
-400
-6% -$16K 0.09% 111
2019
Q4
$332K Buy
6,934
+2,500
+56% +$121K 0.09% 115
2019
Q3
$221K Hold
4,434
0.07% 147
2019
Q2
$237K Buy
+4,434
New +$232K 0.07% 139

Other funds holding NTR

Mraz Amerine & Associates's NTR Position: Q2 2026 in Review

Mraz Amerine & Associates reduced its Nutrien (NTR) stake by 0.41% in Q2 2026, selling an estimated $6.64K and leaving 23,130 shares worth $1.46M. The position accounts for 0.21% of the portfolio, ranked #75.

Mraz Amerine & Associates first reported a position in NTR in Q2 2019 and has held it in 29 quarters since. The position peaked at $1.75M in Q1 2026. 154 funds tracked by Wall St. Rank hold NTR as of Q2 2026.

  • Mraz Amerine & Associates held 23,130 shares of Nutrien worth $1.46M as of Q2 2026.
  • Mraz Amerine & Associates sold 95 Nutrien shares in Q2 2026, an estimated $6.64K.
  • Nutrien made up 0.21% of Mraz Amerine & Associates's portfolio in Q2 2026, its #75 holding.
  • Mraz Amerine & Associates first reported a position in Nutrien in Q2 2019 and has held it in 29 quarters since.
  • Mraz Amerine & Associates's Nutrien position peaked at $1.75M in Q1 2026.
  • 154 funds tracked by Wall St. Rank held Nutrien as of Q2 2026.

Based on Mraz Amerine & Associates's 13F filing for Q2 2026, filed 16 Jul 2026.